APR 15, 2015 9:26 AM PDT

Team Determines Structure of Toxin in Respiratory Infections

WRITTEN BY: Will Hector
Researchers from the School of Medicine at The University of Texas Health Science Center at San Antonio revealed the molecular structure of the cytotoxin from Mycoplasma pneumoniae, a widespread, highly contagious bacterium that infects the lungs.
Mycoplasmas are the smallest of all bacteria and have proven very difficult to study.
The determination of the structure of the protein, called Community Acquired Respiratory Distress Syndrome (CARDS) toxin, will facilitate drug and vaccine development in asthma and other airway diseases, two members of the research team said. According to the U.S. Centers for Disease Control and Prevention (CDC), 2 million new cases of Mycoplasma pneumoniae infections occur each year in the U.S., but the true extent of the health problem is not known and is probably underestimated.

The finding is in last week's Proceedings of the National Academy of Sciences (PNAS). "We know a lot about how the toxin works, but we did not have its 3-D structure," said corresponding author Joel B. Baseman, Ph.D., professor of microbiology and immunology and director of the Center for Airway Inflammation Research at the UT Health Science Center San Antonio. "The structure shows us the molecular architecture of the protein, which permits the rational design of effective drugs and vaccines to neutralize the injurious effects of CARDS toxin."

"The importance of the structure is that it gives us a detailed picture of the protein machine that causes the damage in the lungs linked to asthma and adult respiratory distress syndrome (ARDS)," said lead author P. John Hart, Ph.D. professor of biochemistry and director of the X-ray Crystallography Core Laboratory at the UT Health Science Center.

Mycoplasmas are the smallest of all bacteria and have proven very difficult to study. Dr. Baseman's laboratory discovered the CARDS Toxin in 2006, a finding that was called, at the time, one of the most important in the field since the discovery of the classical toxins of cholera, diphtheria and pertussis. The latter, pertussis toxin, is the agent that causes whooping cough.

The CARDS toxin structure is unique, said Dr. Hart, who occupies the Ewing Halsell-President's Council Distinguished Chair in Biochemistry at the Health Science Center. "In comparison to cholera and pertussis toxins, which have similar action and molecular architectures, the overall organization of CARDS toxin is completely different," Dr. Hart said.

Mycoplasma pneumoniae is spread by sneezing, coughing, talking and touching hands to the nose. It is thought to be responsible for millions of cases of child and adult asthma. This bacterium infects and colonizes the lungs and secretes the CARDS toxin, resulting in extensive airway injury accompanied by fever, excessive mucus secretion, wheezing and hyper-inflammation. Blocking the toxin could prove to be a major advance in the prevention and care of a wide range of acute and chronic airway diseases, Dr. Baseman said.

(Sources: The Pulmonary Paper; Medical News Today)
About the Author
  • Will Hector practices psychotherapy at Heart in Balance Counseling Center in Oakland, California. He has substantial training in Attachment Theory, Hakomi Body-Centered Psychotherapy, Psycho-Physical Therapy, and Formative Psychology. To learn more about his practice, click here: http://www.heartinbalancetherapy.com/will-hector.html
You May Also Like
AUG 31, 2021
Immunology
Convalescent Plasma Therapy for COVID-19 Doesn't Work
AUG 31, 2021
Convalescent Plasma Therapy for COVID-19 Doesn't Work
After encountering an infectious agent, the immune system begins churning out antibodies—Y-shaped warriors that ne ...
SEP 27, 2021
Cancer
Inflammation Promotes Pancreatic Cancer Progression
SEP 27, 2021
Inflammation Promotes Pancreatic Cancer Progression
Inflammation occurs when the immune response, including immune cells and mediators they produce, protect you from danger ...
OCT 19, 2021
Drug Discovery & Development
Researchers develop a potent antiviral drug for dengue fever
OCT 19, 2021
Researchers develop a potent antiviral drug for dengue fever
Dengue fever is a mosquito borne illness that is widespread, especially in tropical countries. The global incidence of d ...
NOV 08, 2021
Health & Medicine
COVID-19 Vaccines Approved for Children 5-11
NOV 08, 2021
COVID-19 Vaccines Approved for Children 5-11
It has been a long time coming. COVID-19 vaccinations from Pfizer, Moderna, and Johnson and Johnson were offered to all ...
NOV 18, 2021
Immunology
Ultrasound Helps Shuttle Cancer-Killing Antibodies to the Brain
NOV 18, 2021
Ultrasound Helps Shuttle Cancer-Killing Antibodies to the Brain
Antibody therapies harness the immune system's power to fight a broad spectrum of diseases, from cancer to infectiou ...
NOV 21, 2021
Microbiology
Rare Genetic Variant Can Make People Susceptible to Bird Flu H7N9
NOV 21, 2021
Rare Genetic Variant Can Make People Susceptible to Bird Flu H7N9
Zoonosis is a serious health concern, as the COVID-19 pandemic has shown. Viruses that infect one species can acquire ge ...
Loading Comments...